Suppr超能文献

杂交冠状动脉血运重建术与非体外循环冠状动脉搭桥术及经皮冠状动脉介入治疗双支冠状动脉疾病合并左前降支近端狭窄的比较

Hybrid coronary revascularization versus off-pump coronary artery bypass grafting and percutaneous coronary intervention for the treatment of two-vessel coronary artery disease with proximal left anterior descending artery stenosis.

作者信息

Qiu Jiapei, Zhu Pengxiong, Liu Zixiong, Xu Hong, Liu Jun, Zhao Qiang

机构信息

Department of Cardiac Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.

VIP Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.

出版信息

J Thorac Dis. 2019 Jun;11(6):2402-2409. doi: 10.21037/jtd.2019.05.54.

Abstract

BACKGROUND

This study sought to compare clinical outcomes of hybrid coronary revascularization (HCR) with off-pump coronary artery bypass grafting (OPCAB) and percutaneous coronary intervention (PCI) for the treatment of two-vessel coronary artery disease (CAD) including proximal LAD stenosis.

METHODS

From January 2009 to December 2016, 52 patients of two-vessel CAD including proximal LAD stenosis underwent HCR at Rui Jin Hospital. Using propensity score methodology, these patients were matched with those in the OPCAB and PCI cohorts. The primary endpoint during follow-up was main adverse cardiovascular and cerebrovascular events (MACCE).

RESULTS

The intensive care unit (ICU) length of stay (LOS) and the hospital LOS were shorter in the HCR group than in the OPCAB group (ICU LOS: P<0.001; hospital LOS: P=0.027). The mean follow-up time was 59 months (interquartile range, 42 to 79 months). The 8-year freedom from MACCE of the HCR group was higher than that of the PCI group (P=0.008), but similar to that of the OPCAB group (P=0.893).

CONCLUSIONS

HCR provides favorable outcomes for selected patients with two-vessel CAD including proximal LAD stenosis.

摘要

背景

本研究旨在比较杂交冠状动脉血运重建术(HCR)与非体外循环冠状动脉旁路移植术(OPCAB)及经皮冠状动脉介入治疗(PCI)治疗包括左前降支近端狭窄在内的双支冠状动脉疾病(CAD)的临床疗效。

方法

2009年1月至2016年12月,52例包括左前降支近端狭窄的双支CAD患者在瑞金医院接受了HCR治疗。采用倾向评分法,将这些患者与OPCAB组和PCI组的患者进行匹配。随访期间的主要终点是主要不良心血管和脑血管事件(MACCE)。

结果

HCR组的重症监护病房(ICU)住院时间(LOS)和住院总LOS均短于OPCAB组(ICU LOS:P<0.001;住院LOS:P=0.027)。平均随访时间为59个月(四分位间距,42至79个月)。HCR组8年无MACCE生存率高于PCI组(P=0.008),但与OPCAB组相似(P=0.893)。

结论

对于选定的包括左前降支近端狭窄的双支CAD患者,HCR可提供良好的治疗效果。

相似文献

引用本文的文献

本文引用的文献

7
Hybrid revascularization for multivessel coronary artery disease.多支冠状动脉疾病的杂交血运重建。
JACC Cardiovasc Interv. 2014 Nov;7(11):1277-83. doi: 10.1016/j.jcin.2014.05.025. Epub 2014 Nov 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验